These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36994643)

  • 21. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
    BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
    BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments.
    Hong SJ; Kim JH; Yoon JH; Park JH; Yoon JH; Kim YJ; Yu SJ; Cho EJ; Lee JM
    Korean J Radiol; 2024 May; 25(5):438-448. PubMed ID: 38685734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
    Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
    BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
    Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs.
    Cassera MA; Potter KW; Ujiki MB; Swanström LL; Hansen PD
    Surg Endosc; 2011 Apr; 25(4):1088-95. PubMed ID: 20848143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
    van der Reijd DJ; Guerendel C; Staal FCR; Busard MP; De Oliveira Taveira M; Klompenhouwer EG; Kuhlmann KFD; Moelker A; Verhoef C; Starmans MPA; Lambregts DMJ; Beets-Tan RGH; Benson S; Maas M
    Eur Radiol; 2024 Jun; 34(6):3635-3643. PubMed ID: 37987835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
    N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
    Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    Zhuang BW; Li W; Qiao B; Zhang N; Lin MX; Wang W; Kuang M; Lu MD; Xie XY; Xie XH
    Int J Hyperthermia; 2022; 39(1):1143-1151. PubMed ID: 36039777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
    Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
    World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases.
    Liu C; He J; Li T; Hong D; Su H; Shao H
    Abdom Radiol (NY); 2021 May; 46(5):2161-2172. PubMed ID: 33108496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
    Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
    Kang TW; Rhim H; Lee J; Song KD; Lee MW; Kim YS; Lim HK; Jang KM; Kim SH; Gwak GY; Jung SH
    Eur Radiol; 2016 Oct; 26(10):3437-46. PubMed ID: 26747262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
    Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J
    Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ablative margins in percutaneous thermal ablation of hepatic tumors: a systematic review.
    Verdonschot KHM; Arts S; Van den Boezem PB; de Wilt JHW; Fütterer JJ; Stommel MWJ; Overduin CG
    Expert Rev Anticancer Ther; 2023; 23(9):977-993. PubMed ID: 37702571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency Ablation of Hepatocellular Carcinoma with a "Nodule-in-Nodule" Appearance: Long-Term Follow-up and Clinical Implications.
    Kang TW; Rhim H; Song KD; Lee MW; Cha DI; Ha SY; Ahn JH
    Cardiovasc Intervent Radiol; 2017 Mar; 40(3):401-409. PubMed ID: 27933377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.